]>
IRCT20180114038356N2 IRCT 2020-05-23 Kermanshah University of Medical Sciences The effect of resveratrol on anti-HIV hyperglycemia The effect of resveratrol on hyperlipidemia caused by anti-retroviral drug therapy in HIV patients 2019-09-23 anticipated 80 Complete https://irct.ir/trial/41549 interventional Randomization: N/A, Blinding: Triple blinded, Placebo: Used, Assignment: Parallel, Purpose: Supportive, Blinding description: The drugs were identified by the code provided to the treating physician. The test results were then presented to the statistician and then the groups were analyzed based on the code. 3 The effect of resveratrol on reducing cholesterol in people with HIV. Intervention 1: Intervention group. Intervention 2: Control group. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is Because patients are HIV positive and information security must be maintained as much as possible
public Dr. Somayeh Karami Mohajeri
Kerman University of Medical Sciences,Medical University Campus,Haft-Bagh Highway, Kerman, Iran
kerman Iran (Islamic Republic of) 76188355559 009831325239 somayyehkarami@gmail.com Kerman University of Medical Sciences scientific University professor
Kerman University of Medical Sciences,Medical University Campus,Haft-Bagh Highway, Kerman, Iran
kerman Iran (Islamic Republic of) 76188355559 009831325239 somayyehkarami@gmail.com Kerman University of Medical Sciences Iran (Islamic Republic of) Sustainable treatment with triple-drug regimen for at least 12 months. LDL> 130 mg / dL or triglyceride 200-500 mg / dL and HDL> 160 mg / dL, with no regular diet and exercise for at least 3 months 18 years no limit Both Exclusion criteria were: history of pre-antiretroviral lipid disorders, history of cardiovascular and / or cerebral disease, Cushing's syndrome, hypothyroidism, type 1 or type 2 diabetes, renal failure, previous or current treatment with reduced risk factors. Lipid donors, antihypertensive drugs or estrogens, current drug and / or alcohol abuse. B20-B24 Human immunodeficiency virus [HIV] disease Treatment - Drugs Placebo Intervention group Control group Triglyceride. Timepoint: 1 month. Method of measurement: Each patient received 15 ml fasting venous blood before and after 1 month of treatment with resveratrol and placebo and sent to the laboratory. Cholesterol. Timepoint: 1MONTH. Method of measurement: Each patient received 15 ml fasting venous blood before and after 1 month of treatment with resveratrol and placebo and sent to the laboratory. Kermanshah University of Medical Sciences Approved 2019-07-30 Kerman University of Medical Sciences Kerman University of Pharmacy, School of Pharmacy, Third Floor, Nursing Home, Dr. Karma Mohajeri kerman Kerman Iran (Islamic Republic of)